Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Assets Average (2021 - 2026)

Unicycive Therapeutics filings provide 3 years of Assets Average readings, the most recent being $35.1 million for Q4 2024.

  • On a quarterly basis, Assets Average rose 108.85% to $35.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $35.1 million, a 108.85% increase, with the full-year FY2024 number at $22.9 million, up 169.62% from a year prior.
  • Assets Average hit $35.1 million in Q4 2024 for Unicycive Therapeutics, down from $41.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $48.5 million in Q2 2024 to a low of $6.5 million in Q4 2022.
  • Median Assets Average over the past 3 years was $19.2 million (2022), compared with a mean of $23.8 million.
  • The widest YoY moves for Assets Average: up 158.81% in 2023, down 13.0% in 2023.
  • Unicycive Therapeutics' Assets Average stood at $6.5 million in 2022, then soared by 158.81% to $16.8 million in 2023, then skyrocketed by 108.85% to $35.1 million in 2024.
  • The last three reported values for Assets Average were $35.1 million (Q4 2024), $41.6 million (Q3 2024), and $48.5 million (Q2 2024) per Business Quant data.